Instapath Inc. GTM brain

category

market profile

• text: Conventional histology requires tissue preparation; slide-free microscopy seeks to image fresh unsectioned specimens more quickly.
• text: Instapath positions Nova for imaging fresh tissue while preserving samples for later testing.
• text: Digital pathology procurement involves workflow integration and appropriate validation of intended use.

personas

• title: Pathology laboratory director
  pains:

  • Conventional tissue processing can delay access to images.
  • New imaging equipment must fit existing laboratory workflows and training capacity.
• title: Translational research or tissue core director
  pains:

  • Needs digital images while preserving fresh samples for molecular and ancillary testing.
  • Researchers need a way to view and share images across a team.
• title: Hospital clinical technology and procurement lead
  pains:

  • Must assess image quality, intended use and fit with existing processes before purchase.
  • Needs practical evidence that an imaging workflow can be adopted by staff.

icp

• text: Hospital pathology laboratories and clinical centers handling fresh pathology specimens.
• text: Academic medical centers and biomedical research groups requiring tissue imaging with material preserved for downstream analysis.
• text: Laboratories evaluating digital pathology workflows and willing to validate new instruments; account size and case volume are undisclosed.

message pillars

• text: Move from fresh tissue to digital images quickly.
• text: Preserve specimens for downstream analysis.
• text: Make adoption manageable for clinical teams.
• text: Enable digital viewing and sharing.

objections

• objection: Will imaging consume tissue needed for later testing?
  response: The company says Nova requires no cutting or fixing and preserves tissue; confirm compatibility with the relevant specimen workflow.
• objection: Will the device work for our clinical use?
  response: Request a demonstration with representative specimens and assess intended use, image quality and local validation requirements.
• objection: Is this a replacement for a cleared primary diagnosis workflow?
  response: The company describes Nova as a Class I device for microscopic visualization; confirm the specific intended use and regulatory requirements before clinical adoption.

competitors

• name: Leica Biosystems
  why: Aperio whole-slide scanners compete for digital pathology budgets but require prepared slides.
• name: OptraSCAN
  why: Digital pathology scanning and image analysis competes for laboratory digitization budgets; its workflow differs from fresh-tissue imaging.
• name: Roche
  why: VENTANA digital pathology slide scanning is an alternative laboratory imaging workflow.

influencers

• name: Mei Wang
  url: https://instapathbio.com/about
  why: Co-founder and CEO of Instapath.

keywords

• fresh tissue digital pathology
• slide free pathology imaging
• rapid tissue microscopy
• digital pathology device
• non destructive tissue imaging
• pathology specimen imaging
• tissue preservation molecular testing

voice

• Clinical and precise
• Workflow-oriented
• Patient-focused

signals

• text: A pathology lab is evaluating faster imaging of fresh tissue.
• text: A research group needs imaging while preserving tissue for molecular analysis.
• text: A laboratory is planning a digital pathology workflow modernization.

pricing

motion

channels

• Industry associations
• SEO
• demos

confidence

Founders

• name: Mei Wang
  title: Founder
  role: Founder
  bio: I am the co-founder and CEO of Instapath Inc.
• name: Quincy Brown
  title: Founder
  role: Founder
• name: David Tulman
  title: Founder
  role: Founder